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  ABSTRACT 
  Objectives      Early therapy improves outcomes in 
rheumatoid arthritis (RA). It is therefore important to 
improve predictive algorithms for RA in early disease. This 
study evaluated musculoskeletal ultrasound, a sensitive 
tool for the detection of synovitis and erosions, as a 
predictor of outcome in very early synovitis.   
  Methods      58 patients with clinically apparent synovitis 
of at least one joint and symptom duration of ≤3 months 
underwent clinical, laboratory, radiographic and 38 joint 
ultrasound assessments and were followed prospectively 
for 18 months, determining outcome by 1987 American 
College of Rheumatology (ACR) and 2010 ACR/European 
League Against Rheumatism criteria. Sensitivity and 
speciﬁ  city for 1987 RA criteria were determined for 
ultrasound variables and logistic regression models were 
then ﬁ  tted to evaluate predictive ability over and above 
the Leiden rule.   
  Results      16 patients resolved, 13 developed non-RA 
persistent disease and 29 developed RA by 1987 
criteria. Ultrasound demonstrated subclinical wrist, 
elbow, knee, ankle and metatarsophalangeal joint 
involvement in patients developing RA. Large joint and 
proximal interphalangeal joint ultrasound variables had 
poor predictive ability, whereas ultrasound erosions 
lacked speciﬁ  city. Regression analysis demonstrated 
that greyscale wrist and metacarpophalangeal joint 
involvement, and power Doppler involvement of 
metatarsophalangeal joints provided independently 
predictive data. Global ultrasound counts were inferior 
to minimal power Doppler counts, which signiﬁ  cantly 
improved area under the curve values from 0.905 to 
0.962 combined with the Leiden rule.   
  Conclusion      In a longitudinal study, extended ultrasound 
joint evaluation signiﬁ  cantly increased detection of joint 
involvement in all regions and outcome groups. Greyscale 
and power Doppler scanning of metacarpophalangeal 
joints, wrists and metatarsophalangeal joints provides the 
optimum minimal ultrasound data to improve on clinical 
predictive  models  for  RA.      
  Early therapy signiﬁ  cantly improves outcomes in 
rheumatoid arthritis (RA).    1        2    Indeed, data suggest 
that the ﬁ  rst 3 months after symptom onset may 
represent a pathologically distinct phase that trans-
lates into a therapeutic window of opportunity.    3     –      5    
The ability to predict the development of RA accu-
rately in patients with very early synovitis is thus 
important.    6    
  Classiﬁ   cation systems for RA    7        8    and predic-
tive models such as the widely validated Leiden 
rule,    9        10    rely heavily on clinical assessment of the 
extent and pattern of joint involvement. How best 
to deﬁ  ne early RA remains a subject of considerable 
debate    11    heightened by recent publication of the 
2010 American College of Rheumatology (ACR)/
European League Against Rheumatism (EULAR) 
criteria. Musculoskeletal ultrasound has been dem-
onstrated to be more sensitive than clinical assess-
ment in the detection of joint swelling,    12        13    and 
more sensitive than conventional radiography in 
the detection of erosions.    14    It is therefore important 
to evaluate the contribution of ultrasound variables 
as potential predictors of outcome in patients with 
very early disease. 
  Investigators have recently explored the use of 
restricted ultrasound joint counts to predict per-
sistent inﬂ   ammatory arthritis in symptomatic 
patients with hand synovitis or arthralgia present-
ing in the ﬁ  rst 3 months of disease.    15    However, the 
use of ultrasound to predict RA in this early phase 
has not been investigated, and although extended 
joint counts are being investigated as a tool to 
assess response to therapy,    16    they have yet to be 
applied to an unselected population of patients 
with very early synovitis. The aim of this study 
was therefore to evaluate the additional predictive 
ability of extended ultrasound joint counts for RA. 
We ﬁ   rst compared clinical and ultrasound base-
line assessments in very early arthritis. Second, 
we compared ultrasound versus a conventional 
radiography baseline evaluation of bone erosion. 
Finally, we compared ultrasound and clinical vari-
ables for their ability to predict RA as a diagnostic 
outcome. 
  PATIENTS  AND  METHODS 
  Patients 
  Fifty-eight patients with clinically apparent syno-
vitis of at least one joint and inﬂ  ammatory joint 
symptoms (inﬂ  ammatory joint pain, and/or swell-
ing and/or morning stiffness) of 3 months or less 
duration underwent baseline assessment and 
18-month follow-up to determine diagnosis as 
previously described.    3        17    Ethical permission was 
obtained and all patients gave written informed 
consent. Patients were classiﬁ  ed as having RA, reac-
tive arthritis, psoriatic arthritis or miscellaneous 
conditions according to established   criteria.    7        8        18    
    19    In order to compare the distribution of joint 
involvement with established RA, 22 patients with 
newly presenting, treatment-naive RA of over 3 
months’ duration fulﬁ  lling 1987 ACR criteria were 
also recruited.   
▶   Additional  data 
(supplementary tables and 
ﬁ  gures) are published online 
only. To view these ﬁ  les please 
visit the journal online (  http://
ard.bmj.com ). 
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Effusion in the absence of synovial thickening was not classi-
ﬁ  ed as synovitis. Synovial hyperaemia was measured by power 
Doppler in each recess and the maximal score graded according 
to Szkudlarek   et al      23   : 0, absence; 1, isolated signals; 2, conﬂ  uent 
signals in less than half of the synovial area; and 3, conﬂ  uent 
signals in more than half of the synovial area. The presence of 
joint erosion was measured as a binary variable. Global ultra-
sound indices for greyscale synovitis and power Doppler were 
calculated by adding scores from all joints. Global ultrasound 
counts were calculated by adding scores after converting indi-
vidual joint grades to binary variables.   
  Statistical  analysis 
  Analysis of data including logistic regression was performed 
using Stata 10. Comparison of clinical and ultrasound counts 
within and between groups was analysed using McNemar’s 
test and Fisher’s exact test, respectively. Other baseline clinical 
and ultrasound variables were compared between groups using 
Mann–Whitney U or Kruskal–Wallis tests. Intraobserver reliabil-
ity was evaluated by blindly rescoring representative images of 
20 patients for synovitis and power Doppler at least 3 months 
after initial scans, and analysed using κ statistics (see supple-
mentary table S1, available online only).     
  RESULTS 
  Patient  characteristics 
  Patients developing RA by 1987 criteria (VERA) were  signiﬁ  cantly 
older than those in other groups as expected (  table 2  ). Male 
patients were overrepresented in this group (55%) compared 
with the general RA population. No patients in the study had 
received disease-modifying antirheumatic drugs at baseline. 
Two patients (both of whom developed RA) had received a 
short course of prednisolone for 5 and 14 days before recruit-
ment. Both fulﬁ  lled ACR criteria at the time of recruitment. 
Two patients in the group developing non-RA persistent disease 
(VENRA) were RF positive; one had   reactive arthritis, the other 
had psoriatic arthritis. Of ﬁ  ve VENRA patients remaining unclas-
siﬁ  ed, one was treated with   methotrexate and another with 
hydroxychloroquine within 1 month of presentation. The com-
parison group of 22 patients with established RA had a median 
symptom   duration of 28 (IQR 17–65) weeks and median age 55 
(IQR 45–63) years: 73% were women, and 64% were ACPA 
and/or RF positive.     
    Global clinical and ultrasound assessment of patients 
  A total of 4640 sites in 2204 joints was included in the analysis. 
Proportionately more joints were found to be involved by ultra-
sound greyscale assessment than clinical examination in VERA 
(see   table 2  ). Ultrasound assessment led to the reclassiﬁ  cation 
of many patients between monarthritis, oligoarthritis and pol-
yarthritis groups. In particular nine (69%) VENRA patients were 
reclassiﬁ  ed as polyarthritis, and eight (50%) resolving patients 
with a clinical monarthritis were reclassiﬁ  ed as oligo or polyar-
thritis. The distribution of subclinical joint involvement found by 
ultrasound greyscale assessment in six patients with persistent 
disease and a clinical monarthritis at presentation (who without 
erosions could not be classiﬁ  ed as having RA by the 2010 criteria) 
is shown in supplementary ﬁ  gure S1 (available online only).   
    Effect of ultrasound assessment on joint involvement by region 
  Clinical involvement was deﬁ  ned by at least one joint in a given 
region being clinically swollen and ultrasound involvement 
    Clinical, laboratory and radiographic assessment 
  Patients underwent baseline 66 swollen and 68 tender clini-
cal counts. Age, sex, symptom duration, early morning stiff-
ness duration, medication, erythrocyte sedimentation rate, 
C-reactive protein, rheumatoid factor (RF) and anticyclic citrul-
linated peptide antibody (ACPA) status were recorded. In all but 
six patients, none of whom fulﬁ  lled the 1987 or 2010 criteria for 
RA or subsequently developed erosions, baseline conventional 
radiography of hands and feet was recorded, and the presence 
of erosions assessed in a blinded fashion by a single trained 
observer (AF).   
  Ultrasound  assessment 
  Within 24 h of clinical assessment, patients underwent blinded 
ultrasound assessment in a temperature controlled radiology 
suite. Patients were asked not to discuss their symptoms. A sys-
tematic multiplanar greyscale and power Doppler ultrasound 
examination of 92 sites in 38 joints (  table 1  ) was performed 
based upon standard EULAR reference scans    20    using a Siemens 
Acuson Antares scanner (Siemens, Bracknell, UK) and multifre-
quency (5–13 MHz) linear array transducers. For power Doppler 
examinations, the pulse repetition frequency was adjusted to 
provide maximal sensitivity at the lowest possible value for each 
joint, resulting in a pulse repetition frequency of between 610 
and 780. Examinations took between 50 and 60 min depending 
on disease extent and patient mobility.   
  Ultrasound ﬁ  ndings of synovitis, power Doppler positivity and 
erosion were deﬁ  ned according to consensus deﬁ  nitions.    12        20     –      22    
Greyscale synovitis in metacarpophalangeal, proximal inter-
phalangeal and metatarsophalangeal joints was graded from 
0 to 3 based upon the system of Szkudlarek and colleagues,    12    
    23    reclassifying the equivocal ‘minimal’ thickening grade as 
normal: grade 0, normal; grade 1, synovial thickening bulging 
over the line linking the tops of the periarticular bones; grade 
2, grade 1 plus extension to one bone diaphysis; grade 3, grade 
1 plus extension to both bone diaphyses. Synovitis in other 
joints was graded 0–3 as: 0, normal; 1, mild; 2, moderate; and 
3, severe, in which grade 1 demonstrates synovial thickening in 
excess of the mean plus 2 SD of normal range when available.    22    
  Table  1         Synovial intra-articular recesses and periarticular sites 
evaluated by ultrasound   
 Joint    Recess or site 
MCP (1–5), PIP (1–5), MTP (2–5) Dorsal recess
Lateral recess (PIP, MCP 1,2,5 MTP 5)
Volar recess (PIP)
Wrist Intercarpal recesses
Radiocarpal recesses
Ulnarcarpal recesses
Volar carpal recesses
Elbow Anterior recess
Humeroradial joint
Humeroulnar joint
Posterior recess
Shoulder Subdeltoid bursa
Posterior glenohumeral recess
Knee Suprapatellar recess
Medial parapatellar recess
Lateral parapatellar recess
Medial femorotibial joint line
Lateral femorotibial joint line
Ankle Anterior tibiotalar recess
Medial tibiotalar recess
Lateral tibiotalar recess
      MCP, metacarpophalangeal joint; MTP, metatarsophalangeal joint; PIP, proximal 
interphalangeal  joint.   
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and metatarsophalangeals joints (p<0.01). To investigate the 
low levels of clinically apparent metatarsophalangeal joint and 
ankle synovitis in VERA patients, we assessed a comparison 
group of patients with newly presenting RA of more than 3 
months’ duration. Clinical involvement of the proximal inter-
phalangeal, ankle and metatarsophalangeals joints was more 
overt in these patients (  ﬁ  gure 1C  ), with signiﬁ  cantly greater 
involvement of the metatarsophalangeal joints (p<0.05).     
    Detection of erosive disease in early arthritis using ultrasound 
  Ultrasonographic erosions of the hands or feet were detected in 
26 joints of 13 very early arthritis patients (  table 2  ). Using con-
ventional radiography, only one erosion was visible in the wrist 
by the presence of greyscale synovial hypertrophy of at least 
grade 1. The impact of increased sensitivity of ultrasound was 
most marked in the large joints, wrists and metatarsophalan-
geal joints   (  ﬁ  gure 1  , supplementary table S1, available online 
only). Among VERA patients, clinically silent involvement of 
the wrists, elbows, knees, ankles and metatarsophalangeals 
joints was identiﬁ  ed signiﬁ  cantly more often by ultrasound. 
In VENRA patients, metacarpophalangeal joint (p<0.05), 
wrist (p<0.05), elbow (p<0.05) and metatarsophalangeal joint 
(p<0.01) involvement was detected more often by ultrasound 
(supplementary table S2, available online only). Compared with 
groups with persistent outcomes, ultrasound detected less addi-
tional involvement in the resolving group at the wrist (p<0.05) 
  Table  2         Baseline patient demographics and global clinical and ultrasound data   
  Final diagnostic group by 1987 criteria   VERA   VENRA   Resolving 
n  29 13 16
Final diagnosis, n (%)
  RA  29  (100)  0  0
  PsA   0  5  (38)  1  (6.25)
  SLE   0  2  (15)  0
  Parvovirus  related   0  0  1  (6.25)
  Pseudogout   0  0  1  (6.25)
  Reactive   0  1  (8)  0
  Septic   0  0  1  (6.25)
  Unclassiﬁ   ed   0  5  (38) 12  (75)
Age†**   63 (19–82) 45 (18–83) 40 (23–75)
Female, n (%)   13 (45)   9 (69) 10 (63)
Symptoms duration, weeks†   7  (2–12)  6  (3–12)  4  (1–9)
Morning stiffness, min† 120 (30–360) 60 (0–240) 52.5 (0–240)
NSAID use, n (%)   20 (69)   8 (62) 13 (81)
RF positive, n (%)   15 (52)   2 (15)   0
ACPA positive, n (%)   14 (48)   0   0
ESR (mm/h)†   25 (0–104) 24 (4–87) 21.5 (0–102)
CRP (mg/l)†   15 (0–102) 16 (0–83) 16 (0–244)
Swollen joint count of 66†***   8  (1–28)  2  (1–13)  1.5  (1–7)
Tender joint count of 68†*   9  (0–41)  3  (0–19)  2.5  (1–10)
DAS28 score†   4.49  (2.20–6.28)  3.90  (1.66–6.27)  3.57  (1.38–4.94)
Patients meeting ACR criteria at baseline
  1987 ACR criteria, n (%)   12 (41)   0   0
  USGS 1987 ACR criteria, n (%)‡  16  (55)  3  (23)  1  (6)
  2010 ACR/EULAR criteria, n (%)   24 (83)   2 (15)   0
  USGS 2010 ACR/EULAR criteria, n (%)‡  27  (93)  5  (38)  2  (13)
Clinical pattern, n (%)
  Monarthritis   1  (3)  6  (46)  8  (50)
  Oligoarthritis (2–5 joints)   10 (34)   6 (46)   7 (44)
  Polyarthritis (>5 joints)   18 (62)   1 (8)   1 (6)
USGS pattern, n (%)‡
  Monarthritis   0  1  (8)  0
  Oligoarthritis   1  (3)  2  (15) 11  (69)
  Polyarthritis   28 (97) 10 (77)   5 (31)
US variables
 GS  index†***   35 (5–78) 14 (2–38)   6 (2–19)
  GS count of 38†***  15  (5–33)  9  (1–20)  3  (2–12)
 PD  index†***  25  (5–60)  9  (2–26)  5.5  (0–16)
  PD count of 38†***  12  (3–29)  5  (1–13)  3  (0–10)
Presence of erosions
  Radiographic hand/foot erosion, n (%)     1 (3.5)   0   0
  US hand/foot erosion, n (%)   11 (38)   2 (15)   0
  Any US erosion, n (%)  11  (38)  2  (15)  1  (6.25)
   †Median (range). 
  ‡Clinical examination variables have been extended by adding ultrasonographic criteria of joint involvement (USGS grade ≥1) and 
erosion. 
  ACPA, anticyclic citrullinated peptide antibody; ACR, American College of Rheumatoloty; CRP, C-reactive protein; DAS28, disease 
activity score in 28 joints; ESR, erythrocyte sedimentation rate; EULAR, European League Against Rheumatism; GS, greyscale 
ultrasound; NSAID, non-steroidal anti-inﬂ  ammatory drug; PD, power Doppler; PsA, psoriatic arthropathy; RA, rheumatoid arthritis; 
RF, rheumatoid factor; SLE, systemic lupus erythematosus; US, ultrasound. 
 *p<0.05, **p<0.01, ***p<0.001 Kruskal–Wallis test.     
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    Impact of ultrasound measured variables on 1987 and 
2010 RA criteria fulﬁ  lment 
  At baseline, the 1987 ACR criteria identiﬁ  ed 12 out of 29 RA 
patients, and no patients in VENRA and resolving groups. 
Adding ultrasound data identiﬁ  ed 16 RA patients but misclassi-
ﬁ  ed a further four patients (  table 2  ). The 2010 criteria identiﬁ  ed 
26 patients (nine with ultrasound erosions) at baseline including 
two VENRA patients (  table 2  , supplementary table S3, available 
online only). The difference between these values is almost 
entirely accounted for by the 6-week rule, without which 1987 
of a VERA patient. All VERA patients with ultrasound erosions 
at joints besides metacarpophalangeals joints or wrists also had 
erosions at these hand joints, giving a speciﬁ  city of ultrasound 
erosions for RA of 93%. Of 11 VERA patients with ultrasound 
erosions, eight were RF and ACPA positive, one was RF positive 
only and one was seronegative. One RF-negative patient with 
psoriatic arthritis and one with unclassiﬁ   ed disease presented 
with ultrasound wrist erosions. A single resolving patient with 
a diagnosis of septic arthritis presented with an ultrasound ankle 
erosion.   
A
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  Figure  1         Clinical and ultrasound involvement by joint region. Joint region involvement, deﬁ  ned as the presence of at least one clinically swollen joint 
or one joint with ultrasound greyscale synovitis in a given region, in (A) the total cohort of very early arthritis patients, (B) patients who developed a 
diagnosis of rheumatoid arthritis (RA) and (C) an additional cohort of patients with newly presenting, untreated RA of greater than 3 months’ symptom 
duration. (A) Ultrasound demonstrates increased sensitivity compared with clinical examination in all joints overall. (B) Signiﬁ  cantly more clinically 
silent disease in patients developing RA is measured by ultrasound at the wrist, elbow, knee, ankle and metatarsophalangeal (MTP) joints. (C) Proximal 
interphalangeal joint (PIP), ankle and metatarsophalangeal joint disease is clinically more overt in patients with longer RA disease duration.
MCP, metacarpophalangeal joint.       
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and symmetry of metatarsophalangeal joints are most likely to 
suggest a diagnosis of RA if not clinically apparent, and may be 
combined to enhance prediction (  table 3  ). Deriving a minimal 
12-joint power Doppler ultrasound score in a similar manner to 
Naredo   et al      24    increased the AUC in this analysis. By remov-
ing the (less speciﬁ  c) knee joint from this score, a signiﬁ  cantly 
increased AUC of 0.962 was obtained (p<0.05,   ﬁ  gure 2  ).    25          
  DISCUSSION 
  We have demonstrated a diagnostic beneﬁ  t of the increased sen-
sitivity of ultrasound in an early synovitis population. Ultrasound 
assessment results in a considerable shift in disease category 
from monarthritis to oligoarthritis and/or polyarthritis, that is 
greater than that reported in patients with longer disease dura-
tions.    13    This suggests that the increased sensitivity of ultrasound 
may have a greater impact in the very early window. Comparing 
very early with later onset RA supported this, as joints such as 
the metatarsophalangeals joints were more evident clinically 
later in the disease course. The 2010 criteria proved, as expected, 
to be more sensitive at baseline than the 1987 criteria. However, 
they failed to classify all patients ultimately classiﬁ  ed as RA by 
the 1987 criteria. Adding ultrasound variables to the new 2010 
criteria classiﬁ  ed more patients as RA, including several later 
classiﬁ  ed as RA by the 1987 criteria, one with ultrasound ero-
sions. This suggests that the detection of subclinical disease by 
imaging will similarly prove useful in optimising sensitivity and 
speciﬁ  city of the 2010 criteria. 
  Global ultrasound counts improve sensitivity with some loss 
of speciﬁ  city. However, ultrasound of large joints and proximal 
interphalangeals joints is not helpful in predicting RA by the 
1987 criteria. Global ultrasound joint counts therefore increased 
the discriminating ability of the Leiden rule, but require signiﬁ  -
cant scanning time, and performed worse than minimal counts 
by including non-discriminating joints. Harrison and Symmons    26    
showed in the NOAR cohort that persistent synovitis was pre-
dicted by the presence of RF, a tender joint count of greater than 
six and ankle synovitis. However, ultrasound detected signiﬁ  -
cantly more knee and ankle disease in all disease groups in our 
cohort, with no predictive beneﬁ  t. 
  Two further ﬁ  ndings from our data are important: ﬁ  rst, that 
scanning the metacarpophalangeals joints, wrists and metatar-
sophalangeal joints is likely to be of useful predictive value. 
Subclinical ultrasound metatarsophalangeal joint involvement 
in very early arthritis demonstrated very good speciﬁ  city for RA 
by the 1987 criteria. Long established data show that erosive 
metatarsophalangeal joint disease occurs despite the absence of 
symptoms or signs.    27    Such subclinical disease may manifest as 
a positive metatarsophalangeal joint squeeze test, a suggested 
screening tool for possible early RA.    28    Second, power Doppler 
measurements have a uniquely high speciﬁ  city for RA compared 
with other groups, particularly at the metatarsophalangeals 
joints, with combined metacarpophalangeal joint, wrist and 
metatarsophalangeal joint assessments providing excellent AUC 
values. These data are compatible with those of Freeston   et al      15    
who examined associations of inﬂ  ammatory arthritis in a mixed 
population of patients with arthralgia and arthritis, ﬁ  nding that 
high grade power Doppler had good sensitivity and speciﬁ  city 
for persistence. Therefore, in addition to correlations with ero-
sive progression, power Doppler may also have useful predic-
tive power for RA.    29        30    Of particular interest is the increased 
AUC value of power Doppler indices and counts compared 
with greyscale equivalents, suggesting that power Doppler has 
superior speciﬁ  city for RA. Reducing the complexity of power 
criteria identiﬁ  ed 23 VERA patients at baseline. Extending the 
2010 criteria by adding ultrasound data identiﬁ  ed a further eight 
patients, including three with erosions (supplementary table S2, 
available online only). All eight were classiﬁ  ed as RA regardless 
of erosions by increasing the 2010 ‘joints’ score from either two 
or three to the maximum ﬁ  ve. Ultimately, at 18 months the 2010 
criteria failed to classify as RA four out of 29 VERA patients, 
including one patient with ultrasound deﬁ  ned erosions.   
  Sensitivity  and  speciﬁ  city of clinical and ultrasound 
variables for RA by 1987 criteria 
  Clinical and ultrasound variables were assessed by calculating 
sensitivity, speciﬁ   city and area under the receiver operating 
characteristic curve (AUC) for 1987 RA as an outcome (  table 3  ), 
using threshold grades of 1 or more or 2 or more for ultra-
sound variables. Shoulder, elbow, knee and ankle ultrasound 
involvement was discarded from the analysis because of lack of 
speciﬁ  city for RA, despite increased sensitivity (supplementary 
table S2, available online only). Ultrasound variables generally 
improved sensitivity with some loss of speciﬁ  city. Modifying 
this by imposing a higher threshold grade or requiring symme-
try resulted in improved AUC values for ultrasound variables 
in metacarpophalangeal, proximal interphalangeal and metatar-
sophalangeal joint regions compared with clinical equivalents 
(  table 3  ). In this cohort, adding ultrasound to clinical variables in 
the 1987 ACR criteria increased sensitivity at a cost of speciﬁ  city 
resulting in a drop in AUC. However, power Doppler variables 
performed better than greyscale variables. Furthermore, grey-
scale and power Doppler assessments of metatarsophalangeals 
joints exhibited improved sensitivity compared with clinical 
variables, whereas power Doppler variables retained high speci-
ﬁ  city for RA. By combining variables with 100% speciﬁ  city for 
RA (ACPA positivity, metatarsophalangeal joint power Doppler 
grade of 2 or more involvement and a metacarpophalangeal joint 
greyscale count of 8 or greater), 76% of VERA patients were 
identiﬁ  ed, including eight of the 15 ACPA-negative individuals.     
  Logistic  regression  analyses 
  Signiﬁ   cant variables on univariate analysis were entered as 
explanatory variables in logistic regression models with an out-
come of RA by 1987 criteria as the dependent variable, and the 
Leiden score    9    as the independent variable. An AUC was con-
structed to assess contribution to the prediction of RA above 
the Leiden rule for different models (  table 4  ). The AUC for the 
Leiden rule as a continuous variable was 0.905 in this sample, 
similar to the value derived by van der Helm-van Mil   et al.      9    
Global greyscale and power Doppler counts increased the AUC 
for predicting RA (  table 4  ), indicating that ultrasound counts 
provide independently predictive data over and above the 
Leiden score.   
  An important aim of this study was to identify joint regions 
with the greatest potential for use in predictive models. We 
systematically examined individual ultrasound variables in 
combination with the Leiden rule by logistic regression (  table 
4  ). This analysis precludes examination of variables with 100% 
sensitivity or speciﬁ   city, which were therefore omitted. No 
proximal interphalangeal joint ultrasound variables functioned 
as independent predictors. However, highly sensitive variables 
such as greyscale and power Doppler involvement of metacar-
pophalangeal joints and wrists contributed additional predictive 
information. Moreover, highly speciﬁ  c ultrasound variables such 
as high grade greyscale wrist symmetry, high ultrasound counts 
of metacarpophalangeal joints and power Doppler involvement 
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improved the AUC, and has the advantage of reducing scanning 
time. This ﬁ  nding requires validation in larger studies. 
  The increased sensitivity of ultrasound for erosions was 
greater than that in the ESPOIR cohort    31    and of a similar order 
Doppler indices to 12 joints in the manner of Naredo   et al      24    had 
the effect of increasing the AUC, suggesting that joints effective 
for monitoring disease activity also have good speciﬁ  city as pre-
dictors for RA. Removing the knee joint from this index further 
  Table  3         Sensitivity and speciﬁ  city of clinical and ultrasound variables for the prediction of RA   
   Sensitivity   Speciﬁ  city   Positive  LR   Negative  LR   PPV   NPV   AUC 
MCP joints
  MCP clinical involvement 97 69 3 0.05 76 95 0.828
  MCP clinical symmetry 65.5 97 19 0.36 95 74 0.810
 MCP  GS  ≥1 involvement 100 38 2 0 62 100 0.690
 MCP  GS  ≥1 symmetry 93 76 4 0.09 79 92 0.845
 MCP  GS  ≥2 involvement 90 48 2 0.21 63 82 0.690
 MCP  GS  ≥2 symmetry 86 79 4 0.17 81 85 0.828
  MCP GS count ≥8 45 100  0.55 100 64 0.724
 MCP  PD  ≥1 involvement 97 55 2 0.06 68 94 0.759
 MCP  PD  ≥1 symmetry 83 79 4 0.22 80 82 0.810
 MCP  PD  ≥2 involvement 90 66 3 0.16 72 86 0.776
 MCP  PD  ≥2 symmetry 83 83 5 0.21 83 83 0.828
PIP joints
  PIP clinical involvement 62 76 3 0.50 72 67 0.690
  PIP clinical symmetry 41 93 6 0.63 86 61 0.672
 PIP  GS  ≥1 involvement 79 62 2 0.33 68 75 0.707
 PIP  GS  ≥1 symmetry 48 79 2 0.65 70 61 0.638
 PIP  GS  ≥2 involvement 79 66 2 0.32 70 76 0.724
 PIP  GS  ≥2 symmetry 48 90 5 0.58 82 63 0.690
 PIP  PD  ≥1 involvement 76 69 2 0.35 71 74 0.724
 PIP  PD  ≥1 symmetry 45 90 4 0.62 81 62 0.672
 PIP  PD  ≥2 involvement 66 76 3 0.46 73 69 0.707
 PIP  PD  ≥2 symmetry 38 97 11 0.64 92 61 0.672
Wrist joints
  Wrist clinical involvement 69 86 5 0.36 83 74 0.776
  Wrist clinical symmetry 48 93 7 0.56 88 64 0.707
 Wrist  GS  ≥1 involvement 97 41 2 0.08 62 92 0.690
 Wrist  GS  ≥1 symmetry 86 62 2 0.22 69 82 0.741
 Wrist  GS  ≥2 involvement 79 69 3 0.30 72 77 0.741
 Wrist  GS  ≥2 symmetry 52 93 7 0.52 88 66 0.724
 Wrist  PD  ≥1 involvement 93 48 2 0.14 64 88 0.707
 Wrist  PD  ≥1 symmetry 83 66 2 0.26 71 79 0.741
 Wrist  PD  ≥2 involvement 90 48 2 0.21 63 82 0.690
 Wrist  PD  ≥2 symmetry 69 72 2 0.43 71 70 0.707
MTP joints
  MTP clinical involvement 17 100   0.83 100 55 0.586
  MTP clinical symmetry 10 100   0.90 100 53 0.552
 MTP  GS  ≥1 involvement 69 55 2 0.56 61 64 0.621
 MTP  GS  ≥1 symmetry 55 79 3 0.56 73 64 0.672
 MTP  GS  ≥2 involvement 59 72 2 0.57 68 64 0.655
 MTP  GS  ≥2 symmetry 41 83 2 0.71 71 56 0.621
 MTP  PD  ≥1 involvement 52 90 5 0.54 83 65 0.707
 MTP  PD  ≥1 symmetry 35 100   0.66 100 60 0.672
 MTP  PD  ≥2 involvement 38 100   0.62 100 62 0.690
 MTP  PD  ≥2 symmetry 24 100   0.76 100 57 0.621
Other variables
 Leiden  score  ≥8 62 93 9 0.41 90 71 0.776
  1987 ACR criteria (4/7 clinical) 79 90 8 0.23 89 81 0.845
  ACR criteria 4/7 GS 93 65.5 3 0.10 73 91 0.793
  ACR criteria 4/7 PD 86 76 4 0.18 78 85 0.810
  X-ray hand/foot erosion 3.5 100   0.97 100 45 0.517
  US hand/foot erosion 38 93 5.5 0.67 85 60 0.655
 ACPA  positive 48 100   0.52 100 66 0.741
    ACPA positive or MTP PD 
≥2 Involvement or MCP GS count ≥8
76 100  0.24 100 81 0.879
 PD10  index  ≥10 79 93 11.5 0.22 92 82 0.862
      ACPA, anti-cyclic citrullinated peptide antibody; ACR, American College of Rheumatology; AUC, area under the receiver operating 
characteristic curve; GS, ultrasound greyscale; LR, likelihood ratio; metacarpophalangeal joint (MCP) GS ≥1 involvement, MCP joint 
involvement with an ultrasound greyscale grade of at least 1; MCP joint GS count ≥8, at least eight MCP joints with GS involvement 
of grade ≥1; NPV, negative predictive value; PD, ultrasound power Doppler; PD10 index, summed power Doppler grades of MCP 
2–3 joints, wrists and metatarsophalangeal (MTP) 2–3 joints; PIP, proximal interphalangeal joint; PPV, positive predictive value; RA, 
rheumatoid arthritis; US, ultrasound.     
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for erosions in our very early cohort detected only one out of 
29 RA patients This test is therefore not of use in the very early 
window of disease. 
  This study has some shortcomings that we have sought to 
minimise. The low proportion of female RA patients compared 
with a normal population may be a chance ﬁ  nding within a 
small group. Any subtle gender-related differences in RA 
  severity    34    are unlikely to impact on the results of this study. In 
addition, two patients with persistent unclassiﬁ  ed disease that 
could potentially have developed into RA were treated with 
disease-modifying antirheumatic drugs. Our ﬁ  ndings should be 
viewed with this in mind, as to omit treatment would have 
been unethical. We have harmonised any grading used with 
published schemes so as to maximise the applicability of our 
ﬁ  ndings, and have taken precautions to eliminate sources of 
bias, for instance by using temperature controlled facilities to 
minimise power Doppler variability. The main limitation relates 
to the small size of this initial cohort. The sample size required 
to produce diagnostic algorithms using ultrasound measures of 
synovitis with unbiased statistical methods would be consider-
able, and data from the present study should inform the design 
of future studies. We have demonstrated that scanning not only 
the metacarpophalangeal joints, but also the wrist and metatar-
sophalangeal joints with greyscale and power Doppler, is likely 
to provide the optimum ultrasound data to improve on clinical 
predictive models for RA, and have demonstrated the unique 
predictive speciﬁ  city of metatarsophalangeal joint sonography 
and power Doppler measurement for RA. These are vital ﬁ  rst 
steps in the development of validated predictive algorithms 
that include ultrasound variables.     
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of magnitude to that seen by Wakeﬁ  eld   et al  .    14    Although not the 
strongest predictive variable in our analysis, ultrasound erosions 
had a high speciﬁ  city for RA of 93%, greater than that of radio-
graphic erosions in the Leiden undifferentiated cohort (77%).    32    
Sonographers should therefore remain assured that scanning for 
ultrasound erosions is of signiﬁ  cant value in conﬁ  rming clinically 
suspected disease. Although a recent study presented ultrasound 
examination of the ﬁ  fth metatarsophalangeal joint as a useful 
test to conﬁ  rm diagnosis in RA with a mean disease duration 
of 15 months,    33    examining the ﬁ  fth metatarsophalangeal joint 
  Figure  2         Area under the receiver operating characteristic (ROC) curve 
for rheumatoid arthritis (RA)  as an outcome using a 10-joint power 
Doppler index (summed power Doppler grades of metacarpophalangeal 
joints 2–3, wrists and metatarsophalangeal 2–3 joints) combined with 
the Leiden score (grey), versus the Leiden score alone (black). The 
10-joint power Doppler index was entered as an explanatory variable 
in logistic regression analysis with an outcome of rheumatoid arthritis 
RA as the dependent variable and the Leiden score as the independent 
variable. The area under the ROC curve was compared using a non-
parametric algorithm developed by DeLong   et al.   25      
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  Table  4         Impact of ultrasound on prediction of RA: multivariate 
analyses  
 Variables   p  Value     AUC 
Leiden score <0.001 0.905
Global US variables
 Leiden 0.005
0.028} 0.939
 GS  index
 Leiden 0.003
0.078} 0.924 
 GS  count
 Leiden 0.007
0.016} 0.951 
 PD  index
 Leiden 0.006
0.025} 0.942 
 PD  count
 Leiden 0.005
0.010} 0.952 
  PD12 index (after Naredo   et al ) 24 
 Leiden 0.007
0.006} 0.962 
 PD10  index
US joint counts by region
 Leiden 0.003
0.034} 0.939 
  PD hand count
 Leiden 0.002
0.023} 0.936 
  PD MCP count
 Leiden <0.001
0.148} 0.926 
  PD PIP count
 Leiden <0.001
0.080} 0.929 
  PD MTP count
 Leiden 0.005
0.030} 0.939 
  GS hand count
 Leiden 0.004
0.016} 0.943 
  GS MCP count
 Leiden <0.001
0.175} 0.920 
  GS PIP count
 Leiden <0.001
0.547} 0.905 
  GS MTP count
MCP joints
 Leiden 0.007
0.035} 0.930 
 MCP  GS  ≥1 symmetry
 Leiden 0.002
0.049} 0.923
 MCP  GS  ≥2 symmetry
 Leiden 0.001
0.034} 0.932
 MCP  PD  ≥2 involvement
 Leiden 0.002
0.015} 0.937
 MCP  PD  ≥2 symmetry
Wrist joints
 Leiden 0.001
0.013} 0.936
 Wrist  GS  ≥2 involvement
 Leiden <0.001
0.015} 0.939 
 Wrist  GS  ≥2 symmetry
MTP joints
 Leiden 0.001
0.026} 0.933
 MTP  PD  ≥1 involvement
      AUC, area under the receiver operating characteristic curve; GS, ultrasound greyscale; 
GS count, sum of greyscale data when converted to a binary variable; GS index, sum 
of greyscale grades for all scanned joints; metacarpophalangeal (MCP) joint GS ≥1 
involvement, MCP involvement with an ultrasound GS grade of at least 1; PD, ultrasound 
power Doppler; PD10 index, summed power Doppler grades of MCP joint 2–3 joints, wrists 
and metatarsophalangeal (MTP) 2–3 joints; RA, rheumatoid arthritis; US, ultrasound.    
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